BioLineRx Market Cap

BioLineRx has a market cap or net worth of 44.38 million as of December 5, 2025. Its market cap has decreased by -69.17% in one year.

Market Cap

44.38M

Enterprise Value

-1.42M

Revenue

42.17M

Ranking

n/a

PE Ratio

n/a

Stock Price

1.70

Market Cap Chart

Since February 13, 2007, BioLineRx's market cap has increased from 163.03K to 44.38M, an increase of 27,125.18%. That is a compound annual growth rate of 34.71%.

Market Cap History

Date	Market Cap	% Change
Dec 4, 2025	44.38M	-48.12%
Dec 31, 2024	85.55M	-79.39%
Dec 31, 2023	415.08M	314.57%
Dec 29, 2022	100.12M	-67.59%
Dec 30, 2021	308.95M	60.58%
Dec 31, 2020	192.39M	108.80%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 31, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Teva Pharmaceutical Industries	105.66B
Danel (Adir Yeoshua)	2.71B
Kamada	1.33B
BrainsWay	1.08B
Bait Bakfar	1.04B
SofWave Medical	997.78M
Ilex Medical	717.72M
Novolog (Pharm-Up 1966)	644.72M

Market Cap Rankings